|
|
|
Volumn 23, Issue 1 SUPPL. 1, 1996, Pages 13-18
|
|
Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOXORUBICIN;
PACLITAXEL;
ADULT;
AGED;
ALOPECIA;
ARTICLE;
BOLUS INJECTION;
BREAST CANCER;
BREAST METASTASIS;
CANCER COMBINATION CHEMOTHERAPY;
CANCER INVASION;
CANCER SURVIVAL;
CARDIOTOXICITY;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFICACY;
FEMALE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MUCOSA INFLAMMATION;
MYALGIA;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
MULTICENTER STUDIES;
PACLITAXEL;
RANDOMIZED CONTROLLED TRIALS;
UNITED STATES;
|
|
EID: 0029870970
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (22)
|
|
References (0)
|
